SG11201900210PA - Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same - Google Patents
Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for sameInfo
- Publication number
- SG11201900210PA SG11201900210PA SG11201900210PA SG11201900210PA SG11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- production method
- same
- immune function
- acquired immune
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000036737 immune function Effects 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016159824A JP6777911B2 (ja) | 2016-08-17 | 2016-08-17 | 抗インフルエンザ薬による獲得免疫機能低下抑制用発酵乳およびその製造方法 |
| PCT/JP2017/029355 WO2018034279A1 (ja) | 2016-08-17 | 2017-08-15 | 抗インフルエンザ薬による獲得免疫機能低下抑制用組成物およびその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201900210PA true SG11201900210PA (en) | 2019-02-27 |
Family
ID=61196651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201900210PA SG11201900210PA (en) | 2016-08-17 | 2017-08-15 | Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190150463A1 (ja) |
| JP (1) | JP6777911B2 (ja) |
| CN (1) | CN109475585A (ja) |
| SG (1) | SG11201900210PA (ja) |
| WO (1) | WO2018034279A1 (ja) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100278795A1 (en) * | 2007-11-19 | 2010-11-04 | Kaneka Corporation | Lactic acid bacterium-containing preparation |
| EP3040083B1 (en) * | 2013-08-26 | 2018-11-21 | Meiji Co., Ltd. | Antibody titer-increasing agent using lactic acid bacterium |
-
2016
- 2016-08-17 JP JP2016159824A patent/JP6777911B2/ja active Active
-
2017
- 2017-08-15 CN CN201780042693.2A patent/CN109475585A/zh active Pending
- 2017-08-15 WO PCT/JP2017/029355 patent/WO2018034279A1/ja active Application Filing
- 2017-08-15 US US16/317,684 patent/US20190150463A1/en not_active Abandoned
- 2017-08-15 SG SG11201900210PA patent/SG11201900210PA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN109475585A (zh) | 2019-03-15 |
| WO2018034279A1 (ja) | 2018-02-22 |
| JP2018027904A (ja) | 2018-02-22 |
| JP6777911B2 (ja) | 2020-10-28 |
| US20190150463A1 (en) | 2019-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250744A0 (en) | A method for preparing flavociclib and its pharmaceutical preparations | |
| EP3397260A4 (en) | METHODS AND COMPOSITIONS RELATING TO CHOOSERISMS FROM BLOOD PRODUCTS | |
| ZA201608077B (en) | Combination, composition, and method of administering the combination or composition to animals | |
| PL3442480T3 (pl) | Sposób podawania miejscowego | |
| EP3302783A4 (en) | MANUFACTURE OF METAL ORGANIC FRAMEWORK | |
| GB201612853D0 (en) | Solid dosage form production | |
| HK1231416A1 (zh) | 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物 | |
| HK1232229A1 (zh) | '- '-硫代核苷的新型化合物及其製備方法、藥物組合物和應用 | |
| EP3156037A4 (en) | Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition | |
| PL3309138T3 (pl) | Sposób koprodukcji 2,3,3,3-tetrafluoropropylenu i 1,3,3,3-tetrafluoropropylenu | |
| EP3156043A4 (en) | A-gel-intermediate composition, and production method for a-gel-containing o/w emulsion cosmetic using said composition | |
| HK1256362A1 (zh) | 共晶、其製造方法及含有共晶的藥物 | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| SI3672770T1 (sl) | Postopek za proizvodnjo ukrivljenih pohištvenih delov | |
| EP3206771C0 (en) | METHOD FOR ADJUSTING THE COMPOSITION OF CHROMATOGRAPHIC PRODUCTS | |
| EP3538126A4 (en) | BACTERIOCIN PRODUCTION, COMPOSITIONS AND METHODS OF USE | |
| EP3170794A4 (en) | Composition including silicotitanate having sitinakite structure, and production method for same | |
| IL249010A0 (en) | A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient | |
| EP3347380A4 (en) | IMPROVED DELIVERY OF MEDICAMENTS TO THE BRAIN | |
| HK1223837A1 (zh) | 減少過劑量的組合物和方法 | |
| HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
| EP3378493A4 (en) | NOVEL NANOPREPARATION OF ANTICANCER DRUG AND PREPARATION METHOD THEREOF | |
| EP3151826A4 (en) | Omega-3 compositions, dosage forms, and methods of use | |
| EP3398949A4 (en) | USES OF COMPOUND IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF BRAIN GLIOMA | |
| SG11201900210PA (en) | Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same |